ファルシパラム (Falciparum) マラリアにおけるキニジン
Lancet (London, England)
|November 14, 1981
まとめ
口服用キニジンは,14人の患者でプラズモディアム・ファルシパラムのマラリアを効果的に治療し,心臓毒性を示しませんでした. この抗マラリア薬はキニンよりも強力で,最小抑制濃度がin vitroで見られたより低い可能性がある.
科学分野:
- 感染症 感染症は感染症です.
- 薬理学 薬理学とは
- トロピカル・メディシン (熱帯医学)
背景:
- プラズモディウム・ファルシパラム型マラリアは,依然として世界的な健康に対する重大な脅威です.
- 薬剤耐性は,新しい効果的な抗マラリア治療法の開発を必要としています.
- キニンは主要な治療法であったが,その有効性は耐性や副作用によって問題となっている.
研究 の 目的:
- Plasmodium falciparum マラリアの治療における口服用キニジンの有効性と安全性を評価する.
- プラズモディアム・ファルシパラムに対するキニジンとキニンのインビトロ活性を比較する.
主な方法:
- 臨床試験では14人の患者を口服キニジンで治療した.
- 患者のフォローアップでは,35日間の再発を評価しました.
- 試験管培養において,キニジンとキニンの最小抑制濃度 (MIC) を比較した.
主要な成果:
- 14人の患者全員が口服キニジンによる治療に成功しました.
- 12人の患者は35日間,再発症のない状態でした.
- インビトロ研究では,キニジンに対するMICは,キニンと比較して一貫して低いことが示されました.
結論:
- 口服用キニジンは,Plasmodium falciparumマラリアの効果的な治療法である.
- キニジンは,この寄生虫に対するキニンよりも大きな効力を持つ可能性を示しています.
- マラリア治療におけるキニジンの役割に関するさらなる調査が必要である.
関連する概念動画
01:28Depolarizing Blockers: Mechanism of Action
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
01:19Depolarizing Blockers: Pharmocokinetics
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
01:15Pharmacodynamic Models: Linear Concentration–Effect Model
The linear concentration–effect model, underpinned by the principle that pharmacological effect (E) is directly proportional to plasma drug concentration (C), emerges as a pivotal simplification of the Emax model for conditions where C is significantly less than EC50. This model portrays a linear trajectory of the concentration–effect relationship when drug levels are markedly below the EC50 threshold.Despite its inherent assumption of continuous effect augmentation with increasing drug...
01:29Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...